Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
WuXi STA
Pharma
WuXi XDC to funnel IPO proceeds into manufacturing expansions
Following a planned IPO later this month, WuXi XDC aims to plug hundreds of millions of dollars in proceeds back into its Asian manufacturing network.
Fraiser Kansteiner
Nov 7, 2023 10:53am
WuXi plots hundreds of hires at first standalone vaccine plant
Sep 26, 2023 3:35pm
WuXi plans to spin off its bioconjugation subsidiary WuXi XDC
Jul 10, 2023 10:05am
Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia
Sep 30, 2022 9:15am
WuXi expansion tear continues with new oral production plant
Sep 27, 2022 8:45am
BeiGene, Legend, Eisai-Biogen—Fierce Pharma Asia
Jul 8, 2022 10:29am
